Cargando…

Vaccination and natural immunity: Advantages and risks as a matter of public health policy

Detalles Bibliográficos
Autores principales:	Biggs, Adam T., Littlejohn, Lanny F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8957290/ https://www.ncbi.nlm.nih.gov/pubmed/35373176 http://dx.doi.org/10.1016/j.lana.2022.100242

Ejemplares similares

Revisiting the initial COVID-19 pandemic projections
por: Biggs, Adam T, et al.
Publicado: (2021)

Looking for more than hot air: how experimental design can enhance clinical evidence for hyperbaric oxygen therapy
por: Biggs, Adam T., et al.
Publicado: (2022)

Quantifying the RSV immunity debt following COVID-19: a public health matter
por: Billard, Marie-Noëlle, et al.
Publicado: (2022)

India's public health management cadre policy
por: Tiwari, Ritika, et al.
Publicado: (2022)

COVID-19 vaccines: neutralizing antibodies and the alum advantage
por: Hotez, Peter J., et al.
Publicado: (2020)

Reducing COVID-19 outbreaks in prisons through public health-centred policies
por: Henry, Brandy F
Publicado: (2021)

Waning of COVID-19 vaccine effectiveness: individual and public health risk
por: Piechotta, Vanessa, et al.
Publicado: (2022)

The urgent need of public policies for promoting cardiovascular health in Latin-American women
por: Seron, Pamela, et al.
Publicado: (2021)

LGBTQ youth mental health during COVID-19: unmet needs in public health and policy
por: Ormiston, Cameron K, et al.
Publicado: (2022)

Liberties, rights, public policies and water fluoridation
por: de Souza, Antonio Carlos, et al.
Publicado: (2020)

Implications of COVID-19 vaccine effectiveness waning for public health
por: Odone, Anna, et al.
Publicado: (2022)

Mandatory polio vaccination for travellers: protecting global public health
por: Rutter, Paul D, et al.
Publicado: (2014)

Developing COVID-19 vaccine policy in increments
por: Saag, Michael S
Publicado: (2021)

Germany's evolving framework for cannabis legalization and regulation: Select comments based on science and policy experiences for public health
por: Fischer, Benedikt, et al.
Publicado: (2022)

Public-health risks of melamine in milk products
por: Chan, EYY, et al.
Publicado: (2008)

The advantages of metalenses over diffractive lenses
por: Engelberg, Jacob, et al.
Publicado: (2020)

Brazilian public policy for chronic kidney disease prevention: challenges and perspectives
por: Silva, Patrícia Aparecida Barbosa, et al.
Publicado: (2020)

Does family always matter? Public genomes and their effect on relatives
por: Bloss, Cinnamon S
Publicado: (2013)

From routine data collection to policy design: sex and gender both matter in COVID-19
por: Evagora-Campbell, Mireille, et al.
Publicado: (2021)

Where is quality in health systems policy? An analysis of global policy documents
por: Jordan, Keely, et al.
Publicado: (2018)

What are the key pediatric public policy priorities as the COVID-19 pandemic persists?
por: Schleiss, Mark R., et al.
Publicado: (2023)

Emergence of rabies among vaccinated humans in India: a public health concern
por: Goel, Kapil, et al.
Publicado: (2022)

Herd immunity or health equity? – extending HPV vaccination
por: Keddy, Karen H., et al.
Publicado: (2023)

Natural immunity helps overcome the age-related decline of SARS-CoV-2 vaccine immunogenicity
por: Verschoor, Chris P, et al.
Publicado: (2022)

Is electrosynthesis always green and advantageous compared to traditional methods?
por: Yuan, Yong, et al.
Publicado: (2020)

Targeting mitochondrial oxidative phosphorylation: lessons, advantages, and opportunities
por: Machado, Nicole D., et al.
Publicado: (2023)

Political science and global health policy
por: Gómez, Eduardo J, et al.
Publicado: (2022)

The COVID-19 pandemic: a case for epistemic pluralism in public health policy
por: Lohse, Simon, et al.
Publicado: (2020)

Five metaphors about global-health policy
por: Stuckler, David, et al.
Publicado: (2008)

Effectiveness of bivalent mRNA booster vaccines against COVID-19: methodological and public health considerations
por: Stoliaroff-Pepin, Anna, et al.
Publicado: (2023)

A pandemic is no private matter: the COVID-19 vaccine mandate in Austria
por: Druml, Christiane, et al.
Publicado: (2022)

What policy makers need to know about COVID-19 protective immunity
por: Altmann, Daniel M, et al.
Publicado: (2020)

Strengthening public health at the community-level in China
por: Li, Zhongjie, et al.
Publicado: (2020)

Microbial antigen in human milk: a natural vaccine?
por: van den Elsen, Lieke W. J., et al.
Publicado: (2022)

Monkeypox, stigma and public health
por: März, Julian W., et al.
Publicado: (2022)

Bridging the gap between science and policy in global health governance
por: Nay, Olivier, et al.
Publicado: (2022)

Time for global health policy and research leaders to prioritize endometriosis
por: Giudice, Linda C., et al.
Publicado: (2023)

The COVID-19 vaccines rush: participatory community engagement matters more than ever
por: Burgess, Rochelle Ann, et al.
Publicado: (2021)

Nature and Nurture: It Matters for Stem Cells, Too
por: Levit, Rebecca D.
Publicado: (2016)

Then there were seven: a commentary on creating a public involvement strategy group for a policy research unit in behavioural science
por: Green, Dave, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_a8uio56pfkeco30j8oc2lhnv2e